ReviewPharmacology & therapeutics2023

Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.

Yasuyuki Kihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.